États-Unis · Plateformes & données · TipRanks

Isofol Reports Interim Results and Arfolitixorin Study Update

Publié par TipRanks · États-Unis il y a 9 h

Résumé détaillé

Isofol Medical AB ( ($SE:ISOFOL) ) has shared an announcement. Isofol reported net revenue of kSEK 0 in both the third quarter and January–September 2026. The ...

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Isofol Reports Interim Results and Arfolitixorin Study Update

Résumé détaillé

À lire aussi

Tesla, Inc. $TSLA Stock Acquired by First Command Advisory Services Inc.

Fidelis Insurance Holdings boosts dividend by 46.7% to $0.22 a share

Palantir Grew Revenue 96%. The Stock Fell 5%. Here's What I'm Doing.

Earnings call transcript: Ströer Q3 2026 gains on digital ad growth and steady outlook

Jensen Huang built Nvidia into a behemoth. His scandal puts the entire AI boom in jeopardy.

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair

Isofol Reports Interim Results and Arfolitixorin Study Update

Résumé détaillé

Partager

À lire aussi

Tesla, Inc. $TSLA Stock Acquired by First Command Advisory Services Inc.

Fidelis Insurance Holdings boosts dividend by 46.7% to $0.22 a share

Palantir Grew Revenue 96%. The Stock Fell 5%. Here's What I'm Doing.

Earnings call transcript: Ströer Q3 2026 gains on digital ad growth and steady outlook

Jensen Huang built Nvidia into a behemoth. His scandal puts the entire AI boom in jeopardy.

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair